Skip to main content

Table 1 Clinical characteristics of patients

From: Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris

Characteristics Control (n = 40) SAP (n = 60) UAP (n = 60) AMI (n = 60)
Age (years) 62.6 ± 7.9 61.9 ± 9.9 60.6 ± 9.9 62.9 ± 10.3
Sex (male/female) 29/11 44/16 37/23 41/19
Hypertension, n (%) 22 (55) 34 (58) 38 (61.3) 32 (61.2)
Diabetes, n (%) 6 (15) 20 (28) 14 (38.7) 20 (37.3)
Smoking, n (%) 14 (35) 26 (40) 23 (48) 28 (35.8)
BMI (Kg/m2) 23. 2 ± 3.9 24.8 ± 3.0* 25.8 ± 2.7* 25.9 ± 2.6*
TC (mmol/L) 4.52 ± 0.99 4.09 ± 0.95 4.53 ± 1.19 4.40 ± 0.86
TG (mmol/L) 1.68 ± 1.75 1.84 ± 1.04 1.94 ± 1.61 1.82 ± 1.42
LDL-C (mmol/L) 2.71 ± 0.87 2.38 ± 0.81 2.69 ± 1.16 2.71 ± 0.78
HDL-C (mmol/L) 1.20 ± 0.34 1.11 ± 0.41 1.09 ± 0.37 0.94 ± 0.26*
GLU (mmol/L) 5.07 ± 0.9 5.67 ± 2.03 6.22 ± 2.67 6.78 ± 2.91*
Creatinine (μmol/L) 76.28 ± 14.97 88.24 ± 23.03* 82.51 ± 20.29* 87.77 ± 35.23*
CRP (mg/L) 1.49 ± 0.99 2.61 ± 4.04 4.14 ± 4.09* 7.53 ± 7.08*
LVEF (%) 65.7 ± 5.0 62.6 ± 8.5 56.9 ± 12.5* 48.5 ± 10.4*
LVEDD (mm) 46.7 ± 3.2 48.1 ± 3.7 51.5 ± 7.6* 52.7 ± 5.5*
Gensini score 0 44.0 ± 30.2* 52.0 ± 28.4* 61.9 ± 34.5*
Medications, n (%)     
Aspirin 6 (15) 24 (40) 23 (38.3) 25 (41.7)
β-blocker 6 (15) 22 (36.7) 26 (43.3) 30 (50)
ACEI/ARB 10 (25) 22 (36.7) 26 (43.3) 21 (35)
CCB 16 (40) 32 (53.3) 28 (46.7) 26 (43.3)
Statin 9 (22.5) 22 (52) 21 (35) 20 (33.3)
Nitrate 9 (22.5) 9 (15) 16 (26.7) 17 (28.3)
  1. The data are given as the mean ± SD or number of patients. SAP: stable angina pectoris; UAP: unstable angina pectoris; AMI: acute myocardial infarction; TC: total cholesterol; TG: total triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; GLU: fasting glucose; LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic dimension; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: Calcium channel blocker.
  2. *P < 0.05 vs. control.